Ayako Nakayama

Outcomes of Patients Aged 75 Years or Older Undergoing Endotracheal Intubation: An 11-Year Single-Center Retrospective Study

Hideyuki Niwa, Katsuyuki Kojima, Miku Kuriki, Kazumi Hori et autres

jp (code pays fourni par la source)

Improved transfection methods for observation of cytoskeletal structures in primary cultured astrocytes

Chieko Ikoma, Kodai Inoue, Kouta Kasai, Satoko Tsukuda et autres

jp (code pays fourni par la source)

Discovery of ASP2453, a potent and orally bioavailable covalent inhibitor of KRAS G12C for the treatment of solid tumors

Tomoyoshi Imaizumi, Masashi Imanishi, Susumu Yamaki, Itsuro Shimada et autres

jp (code pays fourni par la source)

Public Health Center Strategies to Develop Infection Control Practices for Hospital Sinks in Kawaguchi City

Ayako Nakayama, Ichiro Yamaguchi, Koji Okamoto, Shigefumi Maesaki

jp (code pays fourni par la source)

Discovery of KRAS(G12D) selective degrader ASP3082

Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka, Kohei Inamura et autres

jp (code pays fourni par la source)

Improved transfection methods of primary cultured astrocytes for observation of cytoskeletal structures

Chieko Ikoma, Satoko Tsukuda, Akiko Tamura, Shihoko Nakata et autres

jp (code pays fourni par la source)

Discovery of ASP6918, a KRAS G12C inhibitor: Synthesis and structure–activity relationships of 1-{2,7-diazaspiro[3.5]non-2-yl}prop-2-en-1-one derivatives as covalent inhibitors with good potency and oral activity for the treatment of solid tumors

Tomoyoshi Imaizumi, Itsuro Shimada, Yoshiki Satake, Susumu Yamaki et autres

jp (code pays fourni par la source)

Targeted Infection Control Practices in Japanese Hospitals for Multidrug-Resistant Organisms: Guidance From the Public Health Center

Ayako Nakayama, Ichiro Yamaguchi, Koji Okamoto, Shigefumi Maesaki

jp (code pays fourni par la source)

Public Health Centers' Training Session Programs to Develop Programs on Infection Control Practices for Multidrug-Resistant Organisms in Hospitals in Kawaguchi City, Japan

Ayako Nakayama, Ichiro Yamaguchi, Koji Okamoto, Shigefumi Maesaki

jp (code pays fourni par la source)

[Report on COVID-19 infection prevention and control training sessions for care homes provided by Kawaguchi city and comparison with those provided by the local governments in Japan].

Ayako Nakayama, Koji Okamoto, Izumi Oki

jp (code pays fourni par la source)

Supplementary Data from ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma

T. Futami, Hidetsugu Okada, Rumi Kihara, Tatsuya Kawase et autres

Supplementary Figure S1. from ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma

T. Futami, Hidetsugu Okada, Rumi Kihara, Tatsuya Kawase et autres